Faeth TherapeuticsFTH
13F holders, Q4 2025 (December 31)10holders +1
2new positions
1sold out
1famous investor
$10.67avg. 13F price*
At the end of Q4 2025, 10 institutions reported holding Faeth Therapeutics Inc. (FTH) in their 13F filings, up 1 from Q3 2025. 2 opened new positions and 1 sold out. The largest holders were Ikarian Capital, LLC ($228K), Catalio Capital Management, LP ($157K) and Renaissance Technologies ($123K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Faeth Therapeutics Inc.
- Filed as
- SENSEI BIOTHERAPEUTICS INC (Q4 2025)
- CUSIP
- 81728A207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $3K |
| Exits | 1 | $8K |
All 13F filers, Q3 2025 → Q4 2025: 1,401 shares bought and 2,489 shares sold, net −1,088 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 10 holders
| Ikarian Capital, LLC | 0.03% | Reduce -5.1% | 21,351 | $228K |
| Catalio Capital Management, LP | 0.03% | No change | 14,718 | $157K |
| Renaissance Technologies | 0.00% | Add +10.6% | 11,516 | $123K |
| Bank of America Corp. | 0.00% | Reduce -51.5% | 306 | $3K |
| Citigroup Inc. | 0.00% | New | 294 | $3K |
| JPMorgan Chase & Co. | 0.00% | No change | 32 | $341 |
| Morgan Stanley | 0.00% | No change | 10 | $107 |
| BNP Paribas Financial Markets | 0.00% | No change | 9 | $96 |
| BNP Paribas | 0.00% | New | 7 | $59 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -97.3% | 4 | $43 |
"% of holder's portfolio" is FTH's weight in each manager's 13F, not the share of Faeth Therapeutics Inc. the manager owns.